Presently, Sung H. Lee occupies the position of Chief Financial Officer for MorphoSys AG.

In the past Mr. Lee held the position of Chief Financial Officer & Executive Vice President for Sangamo Therapeutics, Inc. and Vice President-Investor Relations at Gilead Sciences, Inc.

He received an undergraduate degree from the University of California, Irvine and a graduate degree from the University of Southern California.